#patent-system

[ follow ]
#howard-lutnick

Howard Lutnick and the Patent System

Howard Lutnick's nomination as Secretary of Commerce could significantly impact patent policy due to his unique experiences in invention and litigation.

The Next USPTO Director: Duffy's Four Factor Test

The next USPTO Director should embrace a broader approach to patentable subject matter to foster innovation amidst rapid technological advancements.

Howard Lutnick and the Patent System

Howard Lutnick's nomination as Secretary of Commerce could significantly impact patent policy due to his unique experiences in invention and litigation.

The Next USPTO Director: Duffy's Four Factor Test

The next USPTO Director should embrace a broader approach to patentable subject matter to foster innovation amidst rapid technological advancements.
morehoward-lutnick

The Team-Based Reality of Modern Innovation: Average Patent Now Lists More Than Three Inventors

The average number of inventors per utility patent has significantly increased, reflecting a shift towards collaboration in innovation.
#uspto

USPTO Director Vidal Announces December Departure

Kathi Vidal's departure from the USPTO marks a significant transition, especially regarding diversity initiatives and ongoing patent system reforms.

Chamber's GIPC Tells USPTO to Pivot on Coordination Plans with FDA

Activists are urging the FDA to engage more in patent examination processes, but this initiative faces opposition from the U.S. Chamber of Commerce.

USPTO Director Vidal Announces December Departure

Kathi Vidal's departure from the USPTO marks a significant transition, especially regarding diversity initiatives and ongoing patent system reforms.

Chamber's GIPC Tells USPTO to Pivot on Coordination Plans with FDA

Activists are urging the FDA to engage more in patent examination processes, but this initiative faces opposition from the U.S. Chamber of Commerce.
moreuspto

Other Barks & Bites for Friday, November 1: USCO Grants Right to Repair Copyright Exemption to Restaurants; EU Hits Teva with $503 Million Fine for Misusing Patent System; and Former USPTO Director Andrei Iancu Endorses Trump

Teva Pharmaceutical was fined over $500 million for patent misuse, reflecting the EU's commitment to competition enforcement.

Amarin Seeks En Banc Review in Skinny Label Inducement

Hikma's petition challenges the Federal Circuit's skinny label jurisprudence, with implications for patent protections in the pharmaceutical sector.

Congress Must Stop Pushing Bills That Will Benefit Patent Trolls

Patent Eligibility Restoration Act (PERA) reintroduces problematic software and gene patents
PREVAIL Act hinders public petitioning on wrongly granted patents
[ Load more ]